G
Monte Rosa Therapeutics (GLUE)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Monte Rosa Therapeutics (GLUE)
Monte Rosa Therapeutics, Inc. operates as a biotechnology company. The Company focuses on developing molecular glues to degrade disease-causing proteins. Monte Rosa Therapeutics serves customers in the United States and Switzerland.
- USD5.57
- USD6.04
- USD5.50
- USD8.84
- -28.70%
- --
- 76.39k
- 132.64k
- 293M
- 2.44
- -3.80%
Stock News
yesterday
Cramer points to signs the economy is slowing that could bring rate cuts from the Fed
CNBC
yesterday
Broadway Financial Corporation Discloses Receipt of Notice From Nasdaq Regarding Filing Requirement for the Company’s Form 10-K
Yahoo
yesterday
Texas Instruments Stock Jumps as Earnings Edge Estimates
Yahoo
yesterday
Texas Instruments Gives Solid Forecast in Sign of Comeback
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
